Product Name | NebuSelect™ Recombinant Biotinylated Human TREM2, Avi-His-tag |
---|---|
Catalog Number | NBL-240698 |
Alias/Synonyms | TREM2; PLOSL2; TREM2; TREM-2; Trem2a; Trem2b; Trem2c |
Appearance | see COA |
Molecule Weight | His19-Ser174 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q9NZC2-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240698-100ug | 100ug | Inquire | Inquire | |
NBL-240698-1mg | 1mg | Inquire | Inquire | |
NBL-240698-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human TREM2, Avi-His-tag
Catalog#:
NBL-240698
Description:
NebuSelect™ Recombinant Biotinylated Human TREM2, Avi-His-tag(Cat#NBL-240698) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains His19-Ser174.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 20.3 kDa. Due to glycosylation, the protein migrates to 30-45 kDa based on Bis-Tris PAGE result.
Target Name:
TREM2; PLOSL2; TREM2; TREM-2; Trem2a; Trem2b; Trem2c
Target Information:
TREM-2 (Triggering Receptor Expressed on Myeloid cells-2) is a 35 kDa type I transmembrane member of the TREM family and Ig superfamily. Mature human TREM-2- consists of a 156 amino acid (aa) extracellular domain (ECD) with one V-type Ig-like domain, a 21 aa transmembrane (TM) domain, and a 35 aa cytoplasmic tail. TREM-2 forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia.
Amino Acid Sequence:
His19-Ser174
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.